aXichem AB (publ), (aXichem), the developer of innovative natural analogue feed additives and food supplement ingredients, announces that the company has received an order for its feed additive product, aXiphen, from the distributor Chr. Olesen. The order value amounts to about SEK 7 million and delivery will take place to Chr. Olesen's operations in Brazil by call-off during the current year.  

aXiphen is approved as an additive in chicken and pig feed in Brazil and was launched in 2024 by Chr. Olesen at industry fairs such as Nucleovet and South American International Poultry and Swine Show (SIAVS). The launch included targeted PR work to educate and inform stakeholders about aXiphen's potential and how the additive can contribute to more sustainable meat production.

Torsten Helsing, CEO of aXichem comments:

"It is gratifying that Chr. Olesen's team in Brazil sees a positive development for aXiphen and through this order wants to ensure access to our product. Salmonella is a widespread problem for chicken meat producers and for society at large. Many breeders are keen on sustainable production and as aXiphen is a non-antibiotic alternative that inhibits salmonella, the product has generated a lot of interest."

About Chr. Olesen
As a global distributor in the animal health and nutrition industry, Chr. Olesen is committed to delivering high-quality, safe, and sustainable solutions, contributing to the advancement of the animal production sector.

About phenylcapsaicin and aXiphen
The health benefits of chili, with its active ingredient capsaicin have been known for centuries. aXichem's proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, bridged by a triple bond. The result is an innovative natural analogue capsaicin with high purity, where the pungency is greatly reduced.
Production tests and studies have proven the effectiveness of aXiphen^® as an ingredient in poultry feed. A production test on on-floor salmonella prevalence, following the inclusion of 15 ppm phenylcapsaicin in a regular starter diet, was carried out in a full-scale commercial broiler production trial under farming conditions. The production test included about 1.6 million broiler chickens. The trial concluded that under the conditions of the test, the inclusion of 15 ppm phenylcapsaicin in broiler chicken feed statistically significantly reduced the number of farms with salmonella-positive floor boot swabs. The European model for production efficiency, EPEF, showed that breeding efficiency increased by 14% compared to traditional feeding.

This information is such that aXichem is obliged to make public according to the EU's market abuse regulation (EU no. 596/2014). The information was submitted, through the provision of the specified contact person, for publication on 12 February 2025, 08:30 AM CET.

Company contact:

Torsten Helsing, CEO, aXichem AB
Phone: +46 706 863 355 Email: torsten.helsing@axichem.com

About aXichem

aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio-enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Certified advisor for aXichem is Västra Hamnen Corporate Finance AB.
More information is available at www.axichem.com.